| Dear Existing and Potential Investors, COTI will be holding a Company event onTuesday, August 15 at 2PM ET in the McMillan-Binch Boardrooms at the offices of McMillan LLP, Brookfield Place, Suite 4400, 181 Bay Street, Toronto. We are extending an invitation to attend this event to known investors and advisors, as well as potential investors who have expressed interest in learning more about the COTI story. The session will include an update on the COTI-2 Phase 1 clinical trial and corporate financing efforts. Kindly RSVP to this email by end of day on Thursday, August 10 if you will be attending so we may finalize arrangements. Please feel free to extend this invitation to any fellow investor contacts as not all investors have provided their email contact information or requested to be included in our press release email updates. We look forward to seeing you next week. |